QuiaPEG Pharmaceuticals Holding AB (publ) (QUIA.ST)
SEK 0.02
(0.0%)
SEK 0.02
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.37 Million | 5.57 Million | 216 Thousand | 1.86 Million | 4.46 Million | 3.37 Million |
| Cost of Revenue | 2.2 Million | -3.33 Million | -311 Thousand | 4.84 Million | -2.41 Million | -2.59 Million |
| Gross Profit | 2.17 Million | 8.9 Million | 527 Thousand | -2.98 Million | 6.87 Million | 5.97 Million |
| Operating Expenses | 17.68 Million | 19.12 Million | 17.87 Million | 21.94 Million | 20.46 Million | 14.09 Million |
| Selling, General and Administrative Expenses | 13.82 Million | 9.12 Million | 9.62 Million | 13.5 Million | 13.77 Million | 8.54 Million |
| Research and Development Expenses | 3.98 Million | 2.24 Million | 640 Thousand | - | - | - |
| Other Expenses | -119 Thousand | 10 Million | 8.25 Million | 8.44 Million | 6.69 Million | 5.55 Million |
| Cost and Expenses | 19.88 Million | 15.79 Million | 17.56 Million | 26.79 Million | 18.05 Million | 11.5 Million |
| Operating Income | -15.51 Million | -15.79 Million | -17.56 Million | -24.93 Million | -18.05 Million | -11.5 Million |
| Interest Expense | 1.01 Million | 4.29 Million | 2.43 Million | 2.77 Million | 1.52 Million | 550 Thousand |
| Income Tax Expense | - | 4.29 Million | 2.43 Million | 2.77 Million | 1.52 Million | 144.85 Thousand |
| Earnings before Tax | -16.52 Million | -20.08 Million | -20 Million | -27.71 Million | -19.58 Million | -12.05 Million |
| Net Income | -16.52 Million | -24.38 Million | -22.43 Million | -30.48 Million | -21.1 Million | -12.05 Million |
| Earnings Per Share Basic | -0.22 | -6.80 | -17.69 | -47.11 | -29.72 | -20.44 |
| Earnings Per Share Diluted | -0.22 | -6.80 | -17.69 | -47.11 | -29.72 | -20.44 |
| Weighted Average Shares Outstanding | 74.49 Million | 3.58 Million | 1.26 Million | 647.07 Thousand | 710.1 Thousand | 589.7 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 74.49 Million | 3.58 Million | 1.26 Million | 647.07 Thousand | 710.1 Thousand | 589.7 Thousand |
| Gross Margin | 0.50 | 1.60 | 2.44 | -1.61 | 1.54 | 1.77 |
| EBIT Margin | -3.07 | -2.23 | -71.15 | -12.72 | -3.85 | -3.32 |
| Profit Margin | -3.78 | -4.37 | -103.85 | -16.38 | -4.73 | -3.57 |
| EBITDA | -13.43 Million | -13.97 Million | -16 Million | -23.66 Million | -17.19 Million | -11.19 Million |
| Earnings Before Tax Margin | -3.55 | -2.83 | -81.33 | -13.40 | -4.04 | -3.41 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.18 Million | 1.18 Million | 1.31 Million | 4.37 Million | 1.31 Million | 870.5 Thousand |
| Cost of Revenue | 48 Thousand | 48 Thousand | 602.5 Thousand | 2.08 Million | 602.5 Thousand | 499 Thousand |
| Gross Profit | 1.13 Million | 1.13 Million | 714 Thousand | 2.29 Million | 714 Thousand | 371.5 Thousand |
| Operating Expenses | 4.66 Million | 4.66 Million | 3.96 Million | 13.42 Million | 3.96 Million | 4.87 Million |
| Selling, General and Administrative Expenses | 3.65 Million | 3.65 Million | 2.98 Million | - | 2.98 Million | 3.92 Million |
| Research and Development Expenses | 48 Thousand | 48 Thousand | 1.49 Million | - | 1.49 Million | 499 Thousand |
| Other Expenses | 962.5 Thousand | 962.5 Thousand | -510 Thousand | - | - | - |
| Cost and Expenses | 4.71 Million | 4.71 Million | 4.56 Million | 15.5 Million | 4.56 Million | 5.37 Million |
| Operating Income | -3.53 Million | -3.53 Million | -3.25 Million | -15.5 Million | -3.25 Million | -4.5 Million |
| Interest Expense | - | - | - | 1.01 Million | - | - |
| Income Tax Expense | - | - | - | - | - | - |
| Earnings before Tax | -3.58 Million | -3.58 Million | -3.34 Million | -16.52 Million | -3.34 Million | -4.91 Million |
| Net Income | -3.58 Million | -3.58 Million | -3.34 Million | -16.52 Million | -3.34 Million | -4.91 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.04 | - | -0.00 | -1.00 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.04 | - | -0.00 | -0.76 |
| Weighted Average Shares Outstanding | 358.7 Million | 358.7 Million | 74.5 Million | 492.61 Million | 978.91 Million | 4.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 393.37 Million | 393.37 Million | 74.49 Million | 492.61 Million | 978.72 Million | 6.51 Million |
| Gross Margin | 0.96 | 0.96 | 0.54 | 0.52 | 0.54 | 0.43 |
| EBIT Margin | -2.17 | -2.17 | -2.40 | - | -2.40 | -4.08 |
| Profit Margin | -3.04 | -3.04 | -2.54 | -3.78 | -2.54 | -5.65 |
| EBITDA | -2.56 Million | -2.56 Million | -3.16 Million | - | -3.16 Million | -3.55 Million |
| Earnings Before Tax Margin | -2.99 | -2.99 | -2.47 | -3.55 | -2.47 | -5.17 |
9818
600120
RTNXF
WPLCF
QSR
SMHN